AIR21 LEADS IN FDA COMPLIANCE FOR PHARMA SUPPLY CHAIN

Airfreight 2100, Inc., more popularly known as Air21 is the first and only logistics provider to have received from the Food and Drug Administration (FDA) its own License to Operate (LTO) amongst companies handling drug products in the pharmaceutical supply chain in the Philippines in May 2019. Air21 was able to achieve this by deploying resources in its operations and making adjustments accordingly in order to meet FDA’s stringent requirements successfully. With this FDA-issued LTO, Air21’s clients and customers can be assured that products that go through Air21’s warehousing, transportation and delivery systems are fully compliant with government regulations in handling pharmaceutical items.

This LTO is in addition to its other worldclass certifications in Good Storage and Distribution Practices (GSDP) and ISO 9001:2015 Quality Management Systems (QMS) further solidifying Air21’s leading position as a premier provider of logistics services and solutions in the industry.

Air21 has continuously been making significant investments and upgrades to its temperature-controlled logistics assets that further assure customers and clients that their temperature and time sensitive products are handled properly throughout the temperature-controlled supply chain for pharmaceutical products.

Air21 has been servicing the logistics needs of the pharmaceutical industry for more than 15 years already as it continues to follow the highest standards for quality, compliance and process management. Air21 is also licensed to operate at the Philippine Export Zone Authority (PEZA) and Special Economic Zones such as Clark and Subic Bay.

“Air21 is a part of the Lina Group of Companies (OneLGC) with business interests in logistics and supply chain management, IT solutions, industrial waste management, and business process outsourcing. Further to this, Air21, through its affiliate companies in OneLGC, can seamlessly assist client companies in the importation, transport, and distribution of imported and local pharmaceutical products, among other items,” says OneLGC chief commercial officer, Reuben “Beng” Pangan.